X @Bloomberg
Bloomberg·2025-12-04 05:22
French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion https://t.co/jnVAe3Tsze ...
French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion https://t.co/jnVAe3Tsze ...